
    
      A phase 3, randomized, double-blind, placebo-controlled dose escalation and verification
      clinical study to assess the safety and efficacy of pulsed inhaled nitric oxide (iNO) versus
      placebo in subjects at risk for pulmonary hypertension associated with pulmonary fibrosis on
      long term oxygen therapy. (REBUILD)
    
  